Medicine of arthritis of Abbott Laboratories is sentenced to infringe Compensate 1 670 million dollars to Johnson Johnson

Medicine of arthritis of Abbott Laboratories is sentenced to infringe Compensate 1,670 million dollars to Johnson Johnson
Business reports ' Reporter Wang Xiao �h) Because has been sentenced to and has infringed the patented technology of a certain arthritis medicine of Johson Johnson, compensation that Abbott Laboratories Company has to face making 1,670 million dollars to Johson Johnson. Yesterday, the reporter learnt, U.S.A. Texas jury had already made such compensation to decide the company of Abbott Laboratories a few days ago. This it is this that infringe, award greatly most by whom court make in recent years, Abbott Laboratories Company claims and plans to lodge a appeal at this point.
It is reported Johson Johnson accuse the intersection of Abbott Laboratories and company of use for, treat the intersection of rheumatoid and A, joint of disease reach wooden form resist (Humira) Medicine infringe one the intersection of CentocorOrthoBiotech and Remicade that Company have treat the patent under command by Johnson Johnson, and this patent right is co-owned by group and New York University of Johnson Johnson.It is mainly selling the products of pharmacy of Abbott Laboratories that A reaches the wooden form and resists, its sales amount was 4,500 million dollars last year, accounts for 15% of the annual income of prior year of this company.The pharmacy of Abbott Laboratories expressed immediately that would appeal after receiving this judgement. Abbott Laboratories claims in a statement: "We are disappointed to this award, we are confident of our advantage in this case, we will succeed while appealing. "In fact, Johnson Johnson and Abbott Laboratories have had the patent disputes of healing solution and new products all the time, these healing solutions and new products are antitumor necrosis factors, or antitumor necrosis factor classification, and these every year will create the sales amount of hundreds of millions of dollars.
|